Compound Profiles
HGH
Human Growth Hormone | Somatropin
Binds to GH receptors on target tissues, triggering JAK2-STAT5 signaling pathway. Direct effects include lipolysis, protein synthesis, and metabolic regulation.
HGH Fragment 176-191
Growth Hormone Fragment | Fat Loss Peptide
Mimics the lipolytic region of human growth hormone by stimulating fat breakdown through beta-3 adrenergic receptor pathways. Unlike full HGH, it does not bind the growth hormone receptor, so it does not increase IGF-1 levels or interfere with glucose metabolism.
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take HGH with HGH Fragment 176-191?
Yes, but with caution. Redundant lipolytic mechanism. Full HGH already contains the 176-191 sequence, so combining provides diminishing returns for fat loss while adding HGH-related side effects. Regular monitoring is advised.
Is HGH and HGH Fragment 176-191 safe together?
Based on documented research, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.
What are the interactions between HGH and HGH Fragment 176-191?
Redundant lipolytic mechanism. Full HGH already contains the 176-191 sequence, so combining provides diminishing returns for fat loss while adding HGH-related side effects. This assessment has 90% confidence and is based on documented research data.
How should I time HGH and HGH Fragment 176-191?
HGH has a half-life of 3-4 hours (SC), 20-30 minutes (IV) and HGH Fragment 176-191 has a half-life of 15-20 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.